Tiziana Life Sciences (TLSA) Prices 3.33M ADS Follow-On Offering at $3/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures decline as oil surge, high yields stoke inflation worries
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Citi names 5 top chip picks ahead of Q3 earnings
- PepsiCo shares climb after Q3 beat, though company trims profit forecast
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Coronavirus Stocks Mostly Higher as U.S. Cases Grow
March 11, 2020 8:33 AM EDTCoronavirus and related stocks are mostly higher in early trading Wednesday as cases and fear in the U.S. escalates:
News today:
Tiziana Life Sciences plc (Nasdaq: TLSA)GenMark Diagnostics, Inc. (NASDAQ:... MoreTiziana Life Sciences (TSLA) Develops TZLS-50 to Treat COVID-19 Patients with at Risk of Respiratory Failure
March 11, 2020 8:06 AM EDTTiziana Life Sciences plc (Nasdaq: TLSA) announced that its TZLS-501 treatment could be a potential treatment for patients infected with coronavirus (COVID-19) who are at risk of respiratory failure.
Tiziana, a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, is... More



